MREO

Mereo BioPharma

53 hedge funds and large institutions have $84.3M invested in Mereo BioPharma in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

less funds holding

Funds holding:

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

57% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 21

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$775K
Puts
$28K
Net Calls
Net Calls Change

Top Sellers

1 -$5.48M
2 -$2.05M
3 -$1.69M
4
MAM
Monaco Asset Management
Monaco
-$806K
5
Citigroup
Citigroup
New York
-$799K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$172K
27
$128K
28
$109K
29
$98.6K
30
$76.8K
31
$74.9K
32
$51.6K
33
$41.6K
34
$33K
35
$26.4K
36
$24.7K
37
$19K
38
$18.5K
39
$12.5K
40
$11.9K
41
$6.9K
42
$5.28K
43
$4.3K
44
$3.29K
45
$1.98K
46
$1K
47
$396
48
$63
49
$17
50
$4